New heart pump device aims to make risky procedures safer
NCT ID NCT05864248
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a temporary heart pump called the Supira System in 71 people with severe coronary artery disease who need a high-risk procedure to open blocked arteries. The pump supports the heart for up to 4 hours during the procedure to prevent dangerous drops in blood pressure. Researchers are checking if the device is safe and works as intended.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Supira System (temporary heart pump device)
What this could lead to
If successful, this device could provide a safer way to support the heart during complex procedures, potentially reducing complications.
What could go wrong
This is an early feasibility study with only 71 participants, so results may not apply broadly. Device-related adverse events are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
'Instituto Do Coração de São Paulo (InCor)'
São Paulo, 5403-000, Brazil
-
Instituto Dante Pazzanese De Cardiologia (Dante)
São Paulo, 04012-909, Brazil